1. Home
  2. ZVSA vs BQ Comparison

ZVSA vs BQ Comparison

Compare ZVSA & BQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVSA
  • BQ
  • Stock Information
  • Founded
  • ZVSA 2014
  • BQ 2008
  • Country
  • ZVSA United States
  • BQ China
  • Employees
  • ZVSA N/A
  • BQ N/A
  • Industry
  • ZVSA Biotechnology: Pharmaceutical Preparations
  • BQ Other Specialty Stores
  • Sector
  • ZVSA Health Care
  • BQ Consumer Discretionary
  • Exchange
  • ZVSA Nasdaq
  • BQ Nasdaq
  • Market Cap
  • ZVSA 3.5M
  • BQ 3.7M
  • IPO Year
  • ZVSA N/A
  • BQ 2020
  • Fundamental
  • Price
  • ZVSA $1.22
  • BQ $3.08
  • Analyst Decision
  • ZVSA Strong Buy
  • BQ
  • Analyst Count
  • ZVSA 1
  • BQ 0
  • Target Price
  • ZVSA $240.00
  • BQ N/A
  • AVG Volume (30 Days)
  • ZVSA 69.7K
  • BQ 61.7K
  • Earning Date
  • ZVSA 03-24-2025
  • BQ 03-04-2025
  • Dividend Yield
  • ZVSA N/A
  • BQ N/A
  • EPS Growth
  • ZVSA N/A
  • BQ N/A
  • EPS
  • ZVSA N/A
  • BQ N/A
  • Revenue
  • ZVSA N/A
  • BQ $81,208,354.00
  • Revenue This Year
  • ZVSA N/A
  • BQ N/A
  • Revenue Next Year
  • ZVSA N/A
  • BQ N/A
  • P/E Ratio
  • ZVSA N/A
  • BQ N/A
  • Revenue Growth
  • ZVSA N/A
  • BQ N/A
  • 52 Week Low
  • ZVSA $0.98
  • BQ $2.32
  • 52 Week High
  • ZVSA $25.00
  • BQ $7.40
  • Technical
  • Relative Strength Index (RSI)
  • ZVSA 44.26
  • BQ 44.47
  • Support Level
  • ZVSA $1.12
  • BQ $2.95
  • Resistance Level
  • ZVSA $1.29
  • BQ $3.39
  • Average True Range (ATR)
  • ZVSA 0.09
  • BQ 0.31
  • MACD
  • ZVSA -0.01
  • BQ -0.02
  • Stochastic Oscillator
  • ZVSA 37.04
  • BQ 17.19

About ZVSA ZyVersa Therapeutics Inc.

ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.

About BQ Boqii Holding Limited representing

Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.

Share on Social Networks: